Global action plan for influenza vaccines

NAPAPI: North American Countries Join Forces to Prepare for Pandemics

2 April 2012 - The new “North American Plan for Animal and Pandemic Influenza”(NAPAPI) supports a faster and more coordinated response to influenza pandemics in North America. The NAPAPI was jointly released by US President Barack Obama, Mexican President Felipe Calderon, and Canadian Prime Minister Stephen Harper during the North American Leaders Summit. It lays the ground work for mutual assistance during a response, such as sharing personnel as well as vaccines, drugs, diagnostic tests, known collectively as medical countermeasures. The Plan complements national emergency management plans and builds upon the core principles of the International Partnership on Avian and Pandemic Influenza, the standards and guidelines of OIE, WHO, including the IHR (2005), as well as the rules and provisions of the WTO agreement – and the NAFTA.

The report of the GAP-II Consultation is now available

14 MARCH 2012 - WHO releases the report of the Second Consultation on the Global Action Plan for Influenza Vaccines (GAP) held on 12-14 July 2011 in Geneva, Switzerland. The report summarizes the overview of GAP activities in the first five years and proposed action points. This information will inform the upcoming development of a GAP strategy for the next five years.

H1N1 vaccine deployment: lessons learned

Mexico, 2009 WHO/PAHO

2 FEBRUARY 2012 - The WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative is the first coordinated global response to an influenza pandemic.
Between June 2009 and October 2010, WHO, other technical agencies, donor governments, nongovernmental organizations, and vaccine manufacturers and other private-sector stakeholders all worked together to deliver over 78 million doses of pandemic H1N1 vaccine and associated items such as syringes and safety boxes to 77 countries that would otherwise have had no access.
GAP web site is opening a new document section on the H1N1 vaccine deployment experience.

Second Consultation on the Global Action Plan for Influenza Vaccines

12-14 JULY 2011 - WHO hosted the second Consultation on the Global Action Plan for Influenza Vaccines to review the progress for the first time since it was developed in 2006.
More than 100 representatives attended the meeting to review the progress on the key objectives of the plan and to develop a strategic plan of action for the next five years.
The main focus of the second consultation was to discuss countries' experience on pandemic preparedness and vaccine production.

What's new:

News

Flu vaccines safe during pregnancy

May 11 - A review of reports to the Vaccine Adverse Event Reporting System (VAERS) has confirmed that flu vaccines are safe for pregnant women, according to the results of a study presented at the National Foundation for Infectious Disease 15th Annual Conference on Vaccine Research.

Flu license fees nothing to sneeze at for BioDiem

May 8 - BioDiem (Australia) has received license fees totalling around 10% of its market cap from its Live Attenuating Influenza Vaccine ( LAIV) flu vaccine technology. The LAIV technology was developed at the Institute of Experimental Medicine in St Petersburg.

H1N1 discovery paves way for universal flu vaccine: UBC research

May 8 - University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations.

Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark

May 2 - This large cohort study found no evidence of an increased risk of fetal death associated with exposure to an adjuvanted pandemic A/H1N1 2009 influenza vaccine during pregnancy.

Events

5 - 8 September
Incidence, Severity, and Impact

The second international Incidence, Severity, and Impact conference will take place in Munich, Germany. Key focus - global perspective on lessons learned from the 2009 pandemic.

20 - 22 August
2nd International Conference on Vaccines & Vaccination

The Conference will be held at Hilton Chicago/Northbrook, USA. Future influenza vaccines will be debated on 21 August 2012.

July 30-August 1
3rd Annual World Congress of Virus and Infection (WCVI-2012)

The 3rd Annual WCVI-2012 will take place in Guangzhou, China. Influenza and SARS are on the agenda of the Respiratory and Emerging/Re-emerging Viruses session.

9 - 10 July
10th Annual Vaccines Research and Development: All Things Considered

The conference will take place in San Francisco, CA and is part of the 2nd Infectious Diseases World Summit, which includes 2 other concurrent conferences: (1) Influenza Research and Development; (2) 9th Anti-Infectives Partnering & Deal-making.

13 - 16 June
15th International Congress on Infectious Diseases (15th ICID)

The Congress will take place in Bangkok, Thailand. Seasonal, pandemic, and inter-pandemic vaccines will be discussed on Friday, 15 June.

11 - 14 June
World Vaccine Congress Asia 2012

The World Vaccine Congress Asia will be held in June in Grand Copthorne, Waterfront, Singapore. The programme of the event includes World Influenza Congress Asia that will take place on 11 June 2012.

9 - 10 June
Influenza Research and Development

The conference will take place in San Francisco, CA, USA and will cover various aspects of basic research in influenza including virology, pathogenesis, antivirals, antibodies and vaccination. It is part of part of the 2nd Infectious Diseases World Summit

Contact us:

World Health Organization
Global Action Plan for Influenza Vaccines (GAP)
20, avenue Appia
1211 Geneva 27, Switzerland
gap_flu_vaccines@who.int

Key WHO Information

Director-General
Director-General and senior management

Governance of WHO
WHO Constitution, Executive Board and World Health Assembly

Media centre
News, events, fact sheets, multimedia and contacts

International travel and health
Publication on travel risks, precautions and vaccination requirements

World Health Report
Annual report on global public health and key statistics